News

Filter

Current filters:

None

7921 to 7930 of 96601 results

Novartis to buy US generic derma company Fougera for over $1.5 billion

03-05-2012

Further expanding its generic drug foot print, Swiss drug giant Novartis (NOVN: VX) is adding to its…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNovartisPharmaceuticalSandoz

Evotec out-licenses EVT 401 in China to Conba Pharma

03-05-2012

Hamburg, Germany-based Evotec AG (EVT: TecDAX) has granted a development and marketing license on EVT…

Asia-PacificConba PharmaceuticalsEvotecInflammatory diseasesLicensingPharmaceutical

Gen-Probe agrees $3.7 billion acquisition by Hologic

03-05-2012

USA-based Hologic (Nasdaq: HOLX) said it has reached an agreement to acquire Gen-Probe (Nasdaq: ASDAQ)…

Gen-ProbeHologicMergers & AcquisitionsPharmaceutical

Allergan's1 st-qtr profits leap 45%

03-05-2012

USA-based Allergan (NYSE: AGN) reported financial results for the first quarter of 2012, with diluted…

AllerganFinancialPharmaceutical

Generic competition for Lexapro/Cipralex hits Lundbeck's first-quarter

02-05-2012

Danish drugmaker Lundbeck (LUND: DC) yesterday posted a 33% plunge in first-quarter 2012 net profit to…

CipralexFinancialLexaproLundbeckPharmaceutical

BioAlliance Pharma updates on Amep biotherapy development

02-05-2012

its application for a Phase I/II clinical trial with Amep in the metastatic melanoma, and the signing…

AmepBioAlliance PharmaOncologyPharmaceuticalResearch

7921 to 7930 of 96601 results

Back to top